463PReal-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study. (23rd October 2018) - O'Connor, J M; Ducreux, M; Petersen, L N; Öhler, L; Bergamo, F; Metges, J-P; de Groot, J W; Wang, J-Y; García Paredes, B; Dochy, E; Fiala-Buskies, S; Cervantes, A; et al.